A Glanzmann's mutation in β3 integrin specifically impairs osteodast function

Journal of Clinical Investigation

Volumn 107, Issue 9, 2001, Pages 1137-1144

  Feng, Xu ^a   Novack, Deborah V ^a   Faccio, Roberta ^a,b   Ory, Daniel S ^a   Aya, Kunihiko ^a   Boyer, Martin I ^a   McHugh, Kevin P ^a   Ross, F Patrick ^a   Teitelbaum, Steven L ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BARI   (Italy)

^c BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION; GENE STRUCTURE; GLANZMANN DISEASE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; THROMBOCYTE FUNCTION;

EID: 0035015396     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI12040     Document Type: Article

References (37)

1. Osteoclast Biology
2. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
3. Integrins: Versatility, modulation, and signaling in cell adhesion
4. Arggly-asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts
5. A peptidomimetic antagonise of the ανβ3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo
6. Echistatin inhibits the migration of murine prefusion osteoclasts and the formation of multinucleated osteoclast-like cells
7. Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts
8. Cb1 associates with Pyk2 and Src to regulate Src kinase activity, ανβ3 integrin-mediated signaling, cell adhesion, and osteoclast motility
9. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase
10. Bone-targeted Src SH2 inhibitors block Src cel- lular activity and osteoclast-mediated resorption
11. A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo
12. Ser-752→Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia
13. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes
14. Tumor necrosis factor-α activation of nuclear transcription factor-κB in marrow macrophages is mediated by c-Src tyrosine phosphorylation of 1κBα
15. Avian osteoblast conditioned media stimulate bone resorption by targeting multinuclearing osteoclast precursors
16. Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses
17. Requirement of the NPXY motif in the integrin beta 3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo
18. Mutation of the cytoplasmic domain of the integrin beta 3 subunit. Differential effects on cell spreading, recruitment to adhesion plaques, endocytosis, and phagocytosis
19. Regulation of integrin affinity states through an NPXY motif in the beta subunit cytoplasmic domain
20. Breaking the integrin hinge. A defined structural constraint regulates integrin signaling
21. Distinct involvement of beta3 integrin cytoplasmic domain tyrosine residues 747 and 759 in integrin-mediated cytosketetal assembly and phosphotyrosine signaling
22. Restoration of Beta(1)A integrins is required for lysophosphatidic acid-induced migration of Beta(1)-null mouse fibroblastic cells
23. β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
24. Integrin receptor-mediated mobilisation of intranuclear calcium in rat osteoclasts
25. 2+] in rat osteoclasts and mouse-derived osteoclast-like cells
26. Calcitonin down-regulates immediate cell signals induced in human osteoclast-like cells by the bone sialoprotein-IIA fragment through a postintegrin receptor mechanism
27. Tyrosine phosphorylation of p130Cas is involved in actin organization in osteoclasts
28. Engagement of the osteoclast integrin alpha v beta 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity
29. A point mutation in the integrin beta 3 cytoplasmic domain (S752→P) impairs bidirectional signaling through alpha IIb beta 3 (platelet glycoprotein IIb-IIIa)
30. Serine 752 in the cytoplasmic domain of the beta 3 integrin subunit is not required for ανβ3 postreceptor signaling events
31. Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function
32. Outside-in integrin signal transduction. Alpha IIb beta 3-(GP IIb IIIa) tyrosine phosphorylation induced by platelet aggregation
33. Tyrosine phosphorylation of the beta3 cytoplasmic domain mediates integrin-cytoskeletal interactions
34. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
35. Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice
36. Generic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival
37. Integrin signaling